NEW YORK, Aug. 12, 2023 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Party City Holdco Inc. (“Party City” or the “Company”) (NYSE: PRTY, OTC: PRTYQ) and reminds investors of the October 2, 2023 deadline to seek the…

NEW YORK, Aug. 12, 2023 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against BioXcel Therapeutics, Inc. (“BioXcel” or the “Company”) (NASDAQ: BTAI) and reminds investors of the September 5, 2023 deadline to seek the role…

NEW YORK, Aug. 12, 2023 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against RTX Corporation (“RTX” or the “Company”) (NYSE: RTX) and reminds investors of the October 2, 2023 deadline to seek the role of lead plaintiff in…

NEW YORK, Aug. 12, 2023 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against UP Fintech Holding Limited (“UP Fintech” or the “Company”) (NASDAQ: TIGR) and reminds investors of the August 21, 2023 deadline to seek the role…

GUANGZHOU, China, Aug. 12, 2023 /PRNewswire/ — Bio-Thera Solutions, Ltd (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative assets and biosimilars, today announced positive Phase 1 clinical data for BAT8006 (Folate-Receptor-α-ADC) as part of a…

NEW ORLEANS, Aug. 11, 2023 /PRNewswire/ — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 18, 2023 to file lead plaintiff applications in a securities class action lawsuit against NovoCure Limited (NasdaqGS: NVCR), if they purchased the…

NEW ORLEANS, Aug. 11, 2023 /PRNewswire/ — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 8, 2023 to file lead plaintiff applications in a securities class action lawsuit against Seagate Technology Holdings plc (NasdaqGS: STX), if…

NEW ORLEANS, Aug. 11, 2023 /PRNewswire/ — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 5, 2023 to file lead plaintiff applications in a securities class action lawsuit against BioXcel Therapeutics, Inc. (NasdaqCM: BTAI), if they…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.